If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHunting Regulatory News (HTG)

Share Price Information for Hunting (HTG)

Share Price is delayed by 15 minutes
Get Live Data
427.50    -12.50 (-2.84%)
Bid:
424.00
Ask:
425.50
Spread: 1.50 (0.354%)
Market Cap: £623.50m
HTG Live PriceLast checked at - London Stock Exchange

Intraday Hunting Share Chart

Transaction in Own Shares

30 Mar 2026 07:00

RNS Number : 5313Y
Hunting PLC
30 March 2026
 

For Immediate Release

30 March 2026

 

Hunting PLC

 

Transaction in own shares

 

Hunting PLC (the "Company") announces that, in accordance with the terms of its share buyback programme (the "Programme") announced on 17 March 2026, it has purchased the following number of its ordinary shares of 25 pence each ("Ordinary Shares") through Canaccord Genuity Limited for the period from 23 March 2026 to 27 March 2026.

 

Date of transaction:

Number of Shares repurchased:

Volume weighted average price paid (pence)

Lowest price paid per Share (pence):

Highest price paid per Share (pence):

23-Mar-26

13,500

467.25

458.32

472.50

24-Mar-26

13,500

477.15

474.30

480.00

25-Mar-26

13,500

484.06

483.50

485.00

26-Mar-26

13,500

499.50

499.50

499.50

27-Mar-26

12,800

487.64

482.40

491.00

 

The Company intends to cancel the purchased Ordinary Shares. Following cancellation, the Company will have 153,344,637 Ordinary Shares in issue.

 

Following cancellation, the total number of voting rights in the Company will be 153,344,637. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Hunting PLC

Tel: +44 (0) 20 7321 0123

Jim Johnson, Chief Executive

Bruce Ferguson, Finance Director

 

 

 

Sodali & Co (PR)

Tel: +44 (0) 79 3535 1934

James White

Pete Lambie

Tilly Abraham

 

 

 

Canaccord Genuity Limited (Broker)

Tel: +44 (0) 20 7523 8000

Henry Fitzgerald-O'Connor

George Grainger

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it is applied in the UK (the Market Abuse Regulation), a breakdown of trades made by Canaccord Genuity Limited for the period from 23 March 2026 to 27 March 2026 on behalf of the Company as part of the Programme on both an aggregate and individual trade basis is set out below:

 

Aggregate information: 

 

Venue

Volume Weighted Average Price

(pence per Ordinary Share)

Aggregated Volume

XLON

483.07

66,800

 

 Individual transactions:

 

Date of Transaction:

Transaction Time

Volume

Price per Ordinary Share (pence)

Trading Venue

Transaction Reference

23 March 2026

09:43:30

5,000

458.31595

XLON

00106463431TRLO1

23 March 2026

16:36:35

8,500

472.5

XLON

00106522775TRLO1

24 March 2026

13:13:02

6,750

474.3

XLON

00106551078TRLO1

24 March 2026

16:35:26

6,750

480

XLON

00106570880TRLO1

25 March 2026

14:35:20

5,000

485

XLON

00106604203TRLO1

25 March 2026

16:35:19

8,500

483.5

XLON

00106619552TRLO1

26 March 2026

16:36:58

13,500

499.5

XLON

00106665662TRLO1

27 March 2026

10:53:52

5,000

482.4

XLON

00106685340TRLO1

27 March 2026

16:36:06

7,800

491

XLON

00106717164TRLO1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBCGDXUXDDGLR
Date   Source Headline
14th Jan 20257:01 amRNSRestructuring of EMEA Operating Segment
14th Jan 20257:00 amRNS2024 Year-end Trading Update
2nd Dec 20249:30 amRNSDirector/PDMR Shareholding
26th Nov 202411:00 amRNSDirector Shareholding / PDMR
12th Nov 20247:00 amRNSAppointment of Joint Corporate Broker
6th Nov 202410:30 amRNSHolding(s) in Company
29th Oct 20245:00 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSQ3 2024 Trading Update
10th Oct 20244:00 pmRNSPayment of 2024 Interim Dividend in Sterling
3rd Oct 20244:30 pmRNSDirector/PDMR Shareholding
4th Sep 202412:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Aug 20244:30 pmRNSInterim Dividend Payment
29th Aug 20247:01 amRNSSignificant Organic Oil Recovery Contracts
29th Aug 20247:00 amRNSUnaudited results for the six months to 30 June 24
9th Jul 20247:00 amRNSTrading Statement
4th Jun 202412:00 pmRNSNotification of Major Holdings
3rd Jun 20247:00 amRNS$86 million OCTG order from KOC
20th May 20242:30 pmRNSDirectors Shareholding/PDMR transactions
15th May 20243:30 pmRNSDirector Shareholding/PDMR
15th May 20247:00 amRNSMajor OCTG Order
13th May 202410:30 amRNSTR-1: Notification of Major Holdings
25th Apr 20242:00 pmRNSPayment of 2023 Final Dividend in Sterling
19th Apr 20244:10 pmRNSDirectors Shareholding/PDMR
19th Apr 20244:05 pmRNSPayments to Governments year ended 31 Dec 23
17th Apr 20243:15 pmRNSResults of AGM & Directorate Change
17th Apr 20247:00 amRNSAGM, Q1 2024 Trading Update & Directorate Change
8th Apr 20243:36 pmRNSTR-1: notification of major holdings
14th Mar 20244:15 pmRNSAnnual Report and Notice of AGM
12th Mar 20244:45 pmRNSDirector/PDMR Shareholding
6th Mar 20245:20 pmRNSDirector/PDMR Shareholding
4th Mar 202412:30 pmRNSTR1 - Notification of Major Holdings
4th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Feb 20247:00 amRNSResults for the year ended 31 December 2023
23rd Feb 20247:00 amRNSAppointment of Joint Corporate Broker
8th Feb 202411:00 amRNSInvestor presentation via Investor Meet Company
10th Jan 20247:02 amRNSAppointment of Chair of the Company
10th Jan 20247:01 amRNSAppointment of non-executive Director
10th Jan 20247:00 amRNS2023 Year-end Trading Update
5th Jan 202410:00 amRNSDirector Declaration
2nd Jan 202412:50 pmRNSInvestor Presentation - 11 January 2024
13th Dec 20233:35 pmRNSNotification of major holdings
1st Nov 20237:00 amRNSDirector Shareholding/PDMR
31st Oct 20233:27 pmRNSTR-1: Notification of major holdings
31st Oct 20233:26 pmRNSTR-1: Notification of major holdings
26th Oct 20237:00 amRNSQ3 2023 Trading Update
13th Oct 20231:30 pmRNSPayment of 2023 Interim Dividend in Sterling
27th Sep 202310:00 amRNSDirector/PDMR Shareholding
18th Sep 202312:00 pmRNSIndia Facility Opening
13th Sep 20237:00 amRNSCapital Markets Day
7th Sep 20231:57 pmRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.